The incidence of thyroid cancer has increased over the past 30 years. Thyroid cancer is less common in blacks than in persons of white descent, and it has been most common in Asians/Pacific Islanders until recently. OBJECTIVE To determine whether the incidence of thyroid cancer is increasing at disproportionate rates for different races and ethnicities. DESIGN, SETTING, AND PARTICIPANTS Retrospective review. Study participants were individuals with thyroid cancer in the US National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) 13 database from 1992 through 2010. The SEER 13 registry consists of records from Atlanta (Georgia), Connecticut, Detroit (Michigan), Hawaii, Iowa, New Mexico, San Francisco-Oakland (California), Seattle-Puget Sound (Washington), Utah, Los Angeles (California), San Jose-Monterey (California), rural Georgia, and the Alaska Native Tumor Registry.
cally, thyroid cancer incidence is highest in whites, followed by Asians/Pacific Islanders, American Indian/Alaskan natives, and blacks. Thyroid cancer incidence is higher in nonHispanic men and women than in Hispanic men and women ( Table 1) . 1 Our aim in this study was to compare the change in thyroid cancer incidence in whites, blacks, Asians/Pacific Islanders, and American Indian/Alaskan natives and in Hispanics and non-Hispanics. The study period was from 1992 through 2010.
Methods
This study was deemed exempt from review by the Penn State College of Medicine institutional review board. The National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) database (http://seer.cancer.gov/) was used to determine the increase in incidence of thyroid cancer in this retrospective review. The SEER database is a population-based publicly available data set from a government agency that has been gathering data since 1973. Data are contributed by individual registries across the United States.
Many existing studies base their assumptions and conclusions on data from 1973 onward. 2, 8, 9 However, detection of thyroid cancer greatly improved with the introduction of ultrasonography-guided fine-needle aspiration biopsies in the 1980s and 1990s. 10 Therefore, data after 1992 more closely reflect the current state of thyroid cancer in the United States; for this reason, SEER data from 1992 through 2010 were used for this study. In particular, SEER 13 was selected because it has more racial categories than previous SEER data sets. SEER 13 has 4 different categories for race (white, black, Asian/Pacific Islander, and American Indian/Alaskan native) and 2 categories for ethnicity (Hispanic and non-Hispanic). Therefore, individuals of white race are also either Hispanic or non-Hispanic, individuals of black race are also either Hispanic or non-Hispanic, and so forth. The SEER 13 registry consists of records from Atlanta (Georgia), Connecticut, Detroit (Michigan), Hawaii, Iowa, New Mexico, San Francisco-Oakland (California), Seattle-Puget Sound (Washington), Utah, Los Angeles (California), San JoseMonterey (California), rural Georgia, and the Alaska Native Tumor Registry.
The SEER*Stat software version 8.0.4 Joinpoint Regression Program (National Cancer Institute) was used to determine the average annual percentage change (AAPC) in incidence for the thyroid cancer population described by SEER 13 data from 1992 through 2010. The AAPC in thyroid cancer incidence was calculated for each race and ethnicity over the entire study period and over the following 4 specified periods to simplify the comparison: 1992 through 1995, 1996 through 2000, 2001 through 2005, and 2006 through 2010. Joinpoint regression comparability testing for parallelism in annual percentage change in thyroid cancer incidence was conducted to compare trends over the entire study period for each race and ethnicity stratified by sex.
An AAPC can be calculated as a weighted average of the slope of the joinpoint regression curve over a fixed period (an interval with fixed join points). Therefore, the AAPC can be used to compare changes in cancer incidence between groups over specified intervals. Join point enables comparability testing for parallelism to determine whether the annual percentage change regression mean functions are parallel. If the P value is less than .05, then the null hypothesis that the regression mean functions are parallel is rejected. Table 2 lists the AAPC in age-adjusted thyroid cancer incidence by race, ethnicity, and sex. To simplify the comparison of trends in incidence, the AAPCs were calculated over the following 4 periods: 1992 through 1995, 1996 through 2000, 2001 through 2005, and 2006 through 2010. During the study period (1992-2010), the AAPC for thyroid cancer in all races and ethnicities was 5.3% (95% CI, 4.8%-5.7%) per year. Stratification of the study population by race revealed that whites experienced the largest increase in age-adjusted thyroid cancer incidence during the study period (5.6% per year), followed by blacks (4.8% per year), American Indian/ Alaskan natives (3.2% per year), and Asians/Pacific Islanders (2.3% per year) ( Figure 1) . Stratification of the study population by ethnicity revealed that non-Hispanics experienced a larger increase in incidence (5.5% per year) than Hispanics (3.3% per year) ( Figure 2 ). Whites and blacks experienced statistically similar increases in AAPCs, and trend analysis failed to reject parallelism between the groups (P = .25). The AAPCs for white and black women were also similar at 6.1% per year for white women and 5.9% per year for black women, with no significant difference in trends (P = .35). The AAPC for Asians/Pacific Islanders (2.3% per year) was lower than that for whites (5.6% per year) (P < .05). Furthermore, the incidence of thyroid cancer in whites surpassed that of Asians/Pacific Islanders in 2002 ( Figure 3) . Thyroid cancer incidence is now highest in whites. In addition, the AAPC for Asians/Pacific Islanders (2.3% per year) was lower than that for blacks (4.8% per year) (P < .05).
Results
The AAPC for American Indian/Alaskan natives (3.2% per year) was lower than that for whites (5.6% per year) (P < .05) and blacks (4.8% per year) (P < .05). However, the AAPC for American Indian/Alaskan natives (3.2% per year) was not significantly different from that for Asians/Pacific Islanders (2.3% per year) (P = .17).
Over the entire study period, the AAPCs for nonHispanics and Hispanics were significantly different (P < .05). The AAPC for non-Hispanics was 5.5% per year, while the AAPC for Hispanics was 3.3% per year. Similarly, the AAPCs for nonHispanic and Hispanic women were significantly different (P < .05), with an increase of 5.9% per year for non-Hispanic women and an increase of 3.7% per year for Hispanic women. Therefore, thyroid cancer incidence is increasing more quickly in non-Hispanic women than in Hispanic women.
Discussion
The increasing incidence of thyroid cancer across all racial and ethnic groups is an urgent public health concern, and various explanations have been suggested as the underlying cause. Some studies 2, 8, [11] [12] [13] have concluded that this increase in incidence is owing to an increase in the diagnosis of subclinical thyroid cancers, as opposed to an increase in the occurrence of thyroid cancer, because of an increased use of ultrasonography-guided fine-needle aspiration biopsies. These advanced diagnostic techniques enable detection of tumors that are 1 cm or smaller and would otherwise lie dormant and go undetected. 1 0 The findings of other studies 3, [14] [15] [16] suggest that the increase is owing to both an increase in the diagnosis of subclinical thyroid cancers and a true increase in thyroid cancer because of an increase in risk factors. Studies 3, 8, 13, [17] [18] [19] [20] have investigated the possibility that differences in thyroid cancer incidence between whites and blacks are owing to variations in socioeconomic status, resulting in differences in access to health care and detection and diagnosis of subclinical thyroid cancers. Assuming that whites have a higher socioeconomic status and more access to health care, 21 they should have enhanced detection and diagnosis of subclinical thyroid cancer and a greater increase in thyroid cancer incidence than blacks. In addition, under the assumption that Asians/Pacific Islanders have more access to health care, 21 they should also have a greater increase in thyroid cancer incidence than blacks. In the present study, no significant difference in increased thyroid cancer incidence was observed between whites and blacks, but the increased incidence for Asians/Pacific Islanders was significantly lower than that for blacks. This shift in thyroid cancer incidence among different races does not support the theory of access to care as the sole explanation. In 2012, Hispanic men (48%) were less likely to have seen a physician in the past 6 months than non-Hispanic white men (63%) and non-Hispanic black men (58%). 21 Hispanic women (68%) were also less likely to have seen a physician than non-Hispanic white women (76%) and nonHispanic black women (75%). 21 If differences in incidence were due to access to care, then non-Hispanics should have had a greater increase in thyroid cancer incidence than Hispanics. In fact, joinpoint regression comparability testing verified that the larger increase in incidence for non-Hispanics observed in this study was statistically significant. Therefore, differences in the incidence among Hispanics and non-Hispanics support the theory of access to care. Historically, thyroid cancer incidence has been highest in Asians/Pacific Islanders. According to our study, the increase in thyroid cancer incidence was lowest in Asians/ Pacific Islanders. Therefore, in 2002 the incidence of thyroid cancer in whites surpassed that in Asians/Pacific Islanders ( Figure 3 ). Thyroid cancer incidence is now highest in whites.
Differential exposure to risk factors may also cause differences in the increase in thyroid cancer incidence by race and ethnicity. Risk factors for the development of thyroid cancer include female sex, 22 exposure to ionizing radiation, 23 and iodine deficiency or excess. 24, 25 Less understood risk factors include female hormones 26 and obesity. 27, 28 Limitations of our study include the retrospective format and the use of somewhat rigid registry data. Therefore, the SEER registry does not provide us with important adjuvant information such as mode of diagnosis of thyroid nodules (examination vs sonography), body mass index (BMI) or body fat percentage, or previous thyroid surgery, so we could not comment on those differences by race and ethnicity. This information would help us explain the shift in race and ethnicity that we are seeing in this study. For example, mode of diagnosis may vary by different racial and ethnic groups because those with greater access to care would have a greater increase in the diagnosis of thyroid nodules by sonography. In addition, BMI and body fat percentage have a large role in the incidence of diagnosis of thyroid nodules by racial and ethnic groups. Populations with statistically lower BMIs may have thyroid nodules diagnosed more readily by physical examination, so the incidence of thyroid cancer may not increase to as great an extent in those populations. Also, populations with less access to care may have greater BMIs and a higher incidence of thyroid cancer. Finally, racial and ethnic groups who prophylactically have their thyroid glands removed after diagnosis of thyroid nodules would have a lower incidence of thyroid cancer. Therefore, we were In 2002, the thyroid cancer incidence in whites surpassed that in Asians/Pacific Islanders.
